The Readout Loud
Episode 177: Bijan Salehizadeh on Covid tests, plus Verily's moment of truth
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
First, STAT's Erin Brodwin joins us to talk about Verily, Google's big-idea life sciences company that is now under pressure to produce some actual products. Then, health care investor Bijan Salehizadeh calls in to discuss the dearth of rapid Covid-19 tests in the U.S. and how industry, regulators, and lawmakers share the blame. We also take a look at the latest news in biotech, including Biogen's troubled launch of Aduhelm, Moderna's long-term scientific ambitions, and a big day for the Waksal brothers.